Curcumin Trial for Inflammation
Phase 2
30
about 3 years
18+
2 sites in CA
What this study is about
This trial is testing a curcumin supplement to see if it changes inflammation and symptoms in people with clonal cytopenia of undetermined significance, low-risk myelodysplastic syndrome, and myeloproliferative neoplasms. The goal is to understand how curcumin affects chronic inflammation that contributes to these conditions.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-containing Supplement
- 2.Piperine Extract (Standardized)
- 3.Questionnaire Administration
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
dietary supplement
oral (Oral Capsule)
Primary: Mean change in symptom scores for clonal cytopenia of undetermined significance and low risk myelodysplastic syndrome patients, Mean change in symptom scores for myeloproliferative neoplasm (MPN) patients
diagnostic, biopsy